Ethic Inc. Ocugen, Inc. Transaction History
Ethic Inc.
- $5.89 Billion
- Q3 2025
A detailed history of Ethic Inc. transactions in Ocugen, Inc. stock. As of the latest transaction made, Ethic Inc. holds 31,611 shares of OCGN stock, worth $51,209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,611
Previous 40,454
21.86%
Holding current value
$51,209
Previous $39,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OCGN
# of Institutions
110Shares Held
64.6MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$29 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$23.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$8.2 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$6.73 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$5.65 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $351M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...